Page 313 - AIDSBK23C
P. 313

Page 313



               190     Centers for Disease Control and Prevention. Heterosexual transmission of HIV --- 29
                       states, 1999--2002. MMWR. 2004;53:125-129.

               191     Vergis EN, Mellors JW. Natural history of HIV-1 infection. Infect Dis Clin North Am.
                       2000;14:809-825.

               192     Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of
                       protective immunity to HIV infection. Science. 1996;271:324-328.

               193     Quinn TC. Acute primary HIV infection. JAMA. 1997;278:58-62.

               194     Kahn JO, Walker BD. Acute human immunodeficiency virus type I infection. N Engl J
                       Med. 1998;339:33-39.

               195     Rouet F, Elenga N, Msellati P, Montcho C, Viho I, Sakarovitch C, Danel C, Rouzioux C,
                       Leroy V, Dabis F. Primary HIV-1 infection in African children infected through
                       breastfeeding. AIDS. 2002;16:2303-2309.

               196     Coutlee F, Olivier C, Cassol S, et al. Absence of prolonged immunosilent infection with
                       human immunodeficiency virus in individuals with high-risk behaviors. Am J Med.
                       1994;96:42-48.

               197     Tyrer F, Walker AS, Gillett J, Porter K; UK Register of HIV Seroconverters. The
                       relationship between HIV seroconversion illness, HIV test interval and time to AIDS in a
                       seroconverter cohort. Epidemiol Infect. 2003;131:1117-1123.

               198     Tenner-Racz K, Stellbrink HJ, vanLunzen J, et al. The unenlarged lymph nodes of HIV-
                       1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus
                       replication and CD4 T cell proliferation. The impact of highly active antiretroviral
                       therapy. J Exp Med. 1998;187:949-959.

               199     Cornelissen M, Jurriaans S, Prins JM, Bakker M, van der Kuyl AC. Absence of
                       seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years
                       undetectable plasma HIV-1 viral load. AIDS Res Ther. 2006;Feb 16;3:3.

               200     Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial
                       plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med.
                       2001;344:720-725.

               201     Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T
                       cell responses associated with control of viremia. Science. 1997;278:1447-1450.

               202     Noursadeghi M, Katz DR, Miller RF. HIV-1 infection of mononuclear phagocytic cells:
                       the case for bacterial innate immune deficiency in AIDS. Lancet Infect Dis. 2006;6:794-
                       804.
   308   309   310   311   312   313   314   315   316   317   318